Expression of the mucin MUC2, the structural component of the colonic mucus layer, is lowered in ulcerative colitis. Furthermore, interleukin (IL)-10 knockout (IL-10 À/À ) mice develop colitis and have reduced Muc2 levels. Our aim was to obtain insight into the role of Muc2 and IL-10 in epithelial protection. Muc2-IL-10 double-knockout (Muc2/IL-10 DKO ) mice were characterized and compared to Muc2 knockout (Muc2 À/À ), IL-10 À/À and wild-type (WT) mice. Clinical symptoms, intestinal morphology and differences in epithelial-specific protein levels were analyzed. In addition, levels of the proinflammatory cytokines in colonic tissue and serum were determined. IL-10 À/À mice were indistinguishable from WT mice throughout this experiment and showed no clinical or histological signs of colitis. Muc2/IL-10 DKO and Muc2 À/À mice showed significant growth retardation and clinical signs of colitis at 4 and 5 weeks, respectively. Muc2/IL-10 DKO mice had a high mortality rate (50% survival/5 weeks) compared to the other types of mice (100% survival). Microscopic analysis of the colon of Muc2/IL-10 DKO mice showed mucosal thickening, increased proliferation, superficial erosions and a diminished Muc4 expression. Furthermore, pro-inflammatory cytokines were significantly upregulated, both in tissue (mRNA) and systemically in Muc2/IL-10 DKO mice. In conclusion, Muc2/IL-10 DKO mice develop colitis, which is more severe in every aspect compared to Muc2
À/À and IL-10 À/À mice. These data indicate that (i) in case of Muc2 deficiency, the antiinflammatory cytokine IL-10 can control epithelial damage, though to a limited extent and (ii) the mucus layer is most likely a key factor determining colitis. KEYWORDS: experimental colitis; goblet cell; inflammatory bowel diseases; intestine; mice; mucin Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease, are characterized by chronic inflammation and mucosal tissue damage of parts of the gastrointestinal tract. They are thought to be caused by combined genetic, environmental, immunoregulatory and epithelial factors. 1, 2 Interleukin (IL)-10 contributes to maintaining intestinal homeostasis by suppressing pro-inflammatory cytokine production.
1,3,4 IL-10-deficient (IL-10 À/À ) mice spontaneously develop chronic colitis, of which severity is dependent on both strain background and environmental factors. [4] [5] [6] Relocation of IL-10 À/À mice from specific pathogen-free, conventional environments into germ-free isolators eliminates immune system activation and colitis development. 7, 8 The intestinal epithelium and mucus layer protect underlying tissues from potentially noxious agents in the lumen. The mucus layer is composed of mucins and one secretory mucin in particular, Muc2, is abundantly expressed in human, rat and mouse colonic epithelium. [9] [10] [11] [12] [13] We recently found that intestinal loss of Muc2, affecting the protective capacities of the mucus layer, leads to colonic inflammation in mice.
14 Furthermore, the activity of mucosal inflammation in human UC correlates significantly with lowered MUC2 synthesis and secretion. 15, 16 In the present study, we investigated the intestinal protective capacities of a Muc2/IL-10 double-knockout (Muc2/ IL-10 DKO ) mouse model, determining whether combined defects in the immunoregulatory and epithelial factors could exacerbate the pathogenesis of inflammation. To this aim, we compared clinical symptoms and intestinal pathology of these mice to those matched Muc2 À/À and IL-10 À/À mice. By doing so, this animal model is the first to provide insight into contributions of both immunological and epithelial abnormalities, that is IL-10 and Muc2 deficiency, to the severity of colonic inflammation.
MATERIALS AND METHODS Animals
The previously described heterozygous Muc2-129SV mice and IL-10 À/À -BL6 mice (a kind gift from Dr M Mähler, Hanover, Germany), designated IL-10 tm1Cgn were bred to generate heterozygous double-knockout mice. 6, 14, 17 These were then bred with each other to generate homozygous Muc2/IL-10 DKO mice. Throughout the crossing procedure, the targeted Muc2 and IL-10 genes were monitored via PCR assays performed on genomic DNA isolated from tail clips. 6, 18 The mice were housed in the same specific pathogen-free environment, and all animal care and procedures complied with institutional guidelines (Erasmus MC-Animal Ethics Committee, Rotterdam, The Netherlands). (Table 1 ). Epithelial-cell proliferation was determined by in vivo DNA labeling with bromodeoxyuridine (BrdU), injected intraperitoneally 30 mg/kg body weight (Sigma, St Louis, MO, USA) 1 h prior to killing. 21, 22 Small intestine and colon were excised and either fixed in 4% (w/v) paraformaldehyde in PBS, stored in RNA later (Qiagen, Venlo, The Netherlands) at À201C or frozen in liquid nitrogen and stored at À801C.
Experimental Setup

Histology and Histological Grading
Tissue fixed in 4% (w/v) paraformaldehyde in PBS was prepared for light microscopy and 5-mm thick sections were stained either by (1) hematoxylin and eosin or (2) Alcian blue (AB) at pH 2.5 followed by periodic acid/Schiff 's reagent (PAS) as described previously. 23 Intestinal inflammation was characterized by number of goblet cells, mucosal thickening, presence of inflammatory cells, general destruction of architecture and presence of ulcers and/or crypt abscesses. All tissue samples were evaluated in a blinded fashion by two independent investigators.
Immunohistochemistry
Five-micrometer thick sections were cut and prepared for immunohistochemistry. 22 Expression of Muc2 was detected by anti-Muc2 antibody H-300, (1:1000 diluted in PBS; SC-15334, Santa Cruz, SanverTech, Heerhugowaard, The Netherlands). To detect goblet cells, anti-trefoil factor 3 (Tff3; 1:3000 diluted in PBS; a generous gift from Professor Dr DK Podolsky) was used. 24 Muc4 was stained using anti-hMUC4 polyclonal antibody (hHA-1) that recognizes a C-terminal peptidic region of MUC4a subunit (1:6000 diluted in 1% BSA, 0.1% Triton X-100 in PBS). 25 To visualize BrdU incorporation, sections were incubated with anti-BrdU (1:250 diluted in PBS; Boehringer Mannheim, Mannheim, Germany).
26 CD3 þ cells were detected using an anti-human CD3 (1:800 diluted in 1% BSA, 0.1% Triton X-100 in PBS; A0452, DAKO, Heverlee, Belgium).
14 Quantitative Real-Time PCR mRNA expression levels of the mucins Muc1, -3 and -4, as well as the endogenous housekeeping gene b-actin were quantified using real-time PCR analysis based upon the intercalation of SYBR s Green on an ABI Prism 7700 sequence detection system (PE Applied Biosystems). 14 Mucin 2-interleukin 10-deficient mice: double trouble M van der Sluis et al OLIGO 6.22 software (Molecular Biology Insights, Cascade, CO, USA) and purchased from Invitrogen (Breda, The Netherlands). In addition, mRNA expression levels of tumor necrosis factor alpha (TNF-a), IL-1b and IL-6 as well as b-actin were quantified.
14 Serum Cytokine Levels Serum was obtained from coagulated blood collected by heart puncture (15 min at 371C, then 30 min a 41C) and stored at À201C until further analysis. The concentrations of several cytokines (IL-12, TNF-a, interferon gamma (IFN-g), monocyte chemoattractant protein-1 (MCP-1), IL-10 and IL-6) in serum were determined with a BD Cytometric Bead Array mouse inflammation kit (BD-Pharmingen, San Diego, CA, USA).
Statistical Analysis
All data are expressed as mean ± s.e.m. Statistical significant differences between the three different types of mice over time were assessed by the one-way ANOVA test followed by a Tukey T-test. The Mann-Whitney U-test was used to analyze changes between two groups (PRISM, version 4.00; Graphpad software, San Diego, CA, USA). Differences were considered statistically significant at Po0.05.
RESULTS
Clinical Symptoms
Numbers of Muc2/IL-10 DKO mice were in line with Mendelian predictions, indicating no prenatal selection or death before 4 weeks. However, high mortality was observed at 4 weeks of age ( Figure 1a) . Seven of the 23 mice died between 3 and 4 weeks of age, and three others between 4 and 5 weeks ( Figure 1a ). Therefore, we killed two groups of five and seven Muc2/IL-10 DKO mice at 4 and 5 weeks, respectively. These mice did not contribute to the survival curve. The only surviving mouse was euthanized at 7 weeks of age and was excluded from analysis. None of the WT, IL-10 À/À and Muc2 À/À mice died during the time frame studied. These animals most probably did not die of sepsis caused by translocation of bacteria as assessed by blood culture and analysis of splenic tissue 27 (data not shown). A significant difference (P ¼ 0.008) in body weight was detected at 4 weeks between WT and Muc2/IL-10 DKO mice. Interestingly, WT mice significantly gained weight between 4 and 5 weeks of age (17.2 ± 1.1 vs 22.3 ± 1.4 g, respectively; P ¼ 0.016), whereas weight of Muc2/IL-10 DKO mice stabilized (6.4±0.4 vs 6.7±0.3 g, respectively; P ¼ 0.53). Similarly, although less severe than Muc2/IL-10 DKO mice, 5-week-old Muc2 À/À mice showed significant growth retardation (Figure 1b ). Only at 8 weeks, WT mice were significantly heavier than IL-10 À/À mice, (25.6 ± 0.2 vs 24.2 ± 0.34 g, respectively; P ¼ 0.005).
Furthermore, at 4 weeks, all Muc2/IL-10 DKO mice showed diarrhea and gross bleeding, which persisted until 5 weeks of age, unlike the control WT littermates. DAI scores for Muc2/ IL-10 DKO mice were therefore significantly higher (Figure 1c ). Differences in DAI scores between WT and IL-10 À/À mice are due to variances in weight differences within a group, and are nonsignificant.
Morphological Analysis
In line with the clinical observations, there were no morphological differences in the proximal or distal colon between WT and IL-10 À/À mice at 5 up to 16 weeks. At 34 weeks, the distal colon of IL-10 À/À mice showed mild inflammation characterized by mucosal thickening, influx of inflammatory cells and overall mild distortion of the architecture (data not shown). Mucin 2-interleukin 10-deficient mice: double trouble M van der Sluis et al frequently observed along the crypts in the Muc2/IL-10 DKO , which were hardly seen in all the other types of mice ( Figure 3) . The overall colonic damage increased along the proximal-distal axis and in addition to the histopathology described above, severe ulceration and crypt abscesses were observed in the distal colon of Muc2/IL-10 DKO mice. These characteristics were most pronounced in older mice (5 weeks) and more severe than in the Muc2 À/À mice. The presence of goblet cells in the colonic mucosa was determined by AB/PAS staining, which stains glycoproteins. Goblet cells of the proximal and distal colon were mainly positive for AB at the crypt bases whereas PAS-positive cells were concentrated higher in the crypts in WT and IL-10 
Expression of Goblet-Cell Markers
The intestinal epithelium of Muc2/IL-10 DKO mice showed altered AB and PAS staining, as described above. Therefore, we ascertained the presence and maturation of the goblet-cell lineage in the different mouse models by determining the expression of Tff3 and Muc4. 24, 25, 28, 29 Muc4 and Tff3 were expressed by goblet cells, concentrated mainly in the upper portion of the crypts, in both the proximal and distal colon of WT mice (Figure 5a and c, Tff3, blue panel; Figure 5e and g, Muc4, orange panel). The staining pattern of Muc4 in the IL-10 À/À mice corresponded to the staining pattern of this marker in the WT mice (Figure 5k and l) . Interestingly, there was a decrease of Muc4-positive goblet cells in both the proximal and distal colon of Muc2 À/À mice (Figure 5i and j). Goblet cells were virtually absent in the proximal colon of the Muc2/IL-10 DKO mice using both the goblet-cell markers Tff3 and Muc4 (Figure 5b and f, respectively) . Interestingly, both Tff3 and Muc4 were detectable in goblet cells in the distal colon of the Muc2/IL-10 DKO mice (Figure 5d and h, respectively), but in smaller numbers compared to WT mice. Furthermore, the goblet cells in the distal colon of the Muc2/ IL-10 DKO mice, as observed in the Muc2 À/À mice, had lost their characteristic goblet-like shape (inset of Figure 5c , WT mice vs inset of Figure 5d , Muc2/IL-10 DKO mice).
Expression of the Muc1, Muc3 and Muc4 Genes
The expression of the mucins, Muc1, Muc3 and Muc4, was quantified at RNA level by real-time RT-PCR in the distal colon of each type of mice ( Figure 6 ). Muc1 expression in each type of knockout mouse did not differ compared to control WT littermates. In contrast, Muc3 mRNA was decreased in the distal colon of Muc2 À/À mice and significantly decreased in the Muc2/IL-10 DKO mice compared to WT littermates. Corresponding to the Muc4 protein expression pattern found in the different types of mice ( Figure 5 , orange panel), there were no significant changes in Muc4 mRNA levels between the IL-10 À/À , Muc2 À/À and WT mice, whereas the mRNA expression was significantly decreased in the Muc2/IL-10 DKO mice.
Increased Lymphocyte Infiltration and Expression of Inflammatory Cytokines
Lymphocyte infiltration into the colon was evaluated using an anti-CD3 antibody. In both the proximal and the distal colon of WT and IL-10 À/À mice, single cells in the lamina propria were detected (Figure 7a ). In the Muc2 À/À mice, there was an increase of lymphocyte infiltration, that is CD3-positive cells, in parts of the colon where there were loss of epithelial cells 14 ( Figure 7a ). The Muc2/IL-10 DKO mice showed increased lymphocyte infiltration (compared to both WT and Muc2 À/À mice), characterized by large clusters in both the proximal and the distal colon compared to WT and Muc2 À/À mice (Figure 7a , Muc2/IL-10 DKO mice, showing distal colon, 5 weeks). In addition, there was an increase of lymphocytes along the proximal-distal axis, coinciding with the increase in histological damage seen in the colon of the Muc2/IL-10 DKO mice. Furthermore, mRNA expression showed a significant increase in the inflammatory cytokines TNF-a, IL-1b and IL-6 in the distal colon of Muc2/IL-10 DKO mice compared to WT mice (Figure 7b, 5 weeks) . The mRNA expression levels of these cytokines were not significantly upregulated in IL-10 À/À and Muc2 À/À mice compared to their WT littermates, 5 weeks of age (Figure 7b) . In accordance with the real-time PCR data, expression of inflammatory cytokines IL-12p70, TNF-a, IFN-g, MIP-1 and IL-6 in the serum of Muc2/IL-10 DKO mice was increased compared to WT mice as early as 4 weeks, which persisted as the mice aged (Figure 7c, 5 weeks) .
DISCUSSION
In this paper, we showed that both immunological and epithelial deficiencies in mice lacking the anti-inflammatory cytokine IL-10 and mucosal protector mucin 2 sensitize the intestine to severe colonic inflammation. The morphological, phenotypic and functional alterations observed make this murine model pertinent to study multiple aspects of IBD. 
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One of the most important phenotypic change observed in Muc2/IL-10 DKO mice was growth retardation, which persisted with age and which was more severe than that in Muc2 À/À mice. It is known that the most prominent factor affecting growth is inadequate nutritional intake. 30 Moreover, growth retardation in IBD patients can be correlated with an increase in systemic TNF-a and IL-6 levels. 31, 32 The bodyweight alterations observed both in Muc2 À/À and Muc2/ IL-10 DKO mice support this paradigm, as the weights of these mice correlated with the severity of inflammation. In addition, Muc2/IL-10 DKO animals also show occult blood loss to gross bleeding and diarrhea at 4 weeks, unlike the WT and IL-10 À/À mice. In this respect, the Muc2/IL-10 DKO mouse model seems to recapitulate symptoms well established in Mucin 2-interleukin 10-deficient mice: double trouble M van der Sluis et al children with IBD, for example, growth failure, diarrhea, rectal bleeding and weight loss. 33 However, this mouse model is severe, as the Muc2/IL-10 DKO mice showed a high mortality rate, in contrast to the Muc2 À/À , IL-10 À/À and WT littermates, of which none died during the current time frame (ie up to 7 weeks of age). Histological analysis of the colon of the Muc2/IL-10 DKO mice additionally confirmed severe inflammation. The Muc2/IL-10 DKO mice showed distinct crypt hyperplasia, inflammatory cell infiltration, flattening of epithelial cells and distortion of the lamina propria, which aggravated as the mice aged. This pathology was even more severe in the distal colon, which in addition to the above characteristics, also showed crypt abscesses.
All together, these clinical and histological symptoms indicate that the Muc2/IL-10 DKO mice constitute a good model to study several aspects of IBD, as described above, which À/À and Muc2/IL-10 DKO mice was confirmed by a decrease in Muc4 expression. There was even an almost complete loss of Muc4 protein expression in the goblet cells of the proximal colon in both these types of knockout mice. Loss of Muc4 expression in the colon combined with the significant increase in proliferation in the colon in both the Muc2 À/À and the Muc2/ IL-10 DKO mice is in line with a previous study, in which rat Muc4 was associated with highly/terminally differentiated, non-proliferating epithelial cells. 34 We propose that loss of Muc4 expression is not correlated with the amount of damage (proximal vs distal colon), but to a difference in gobletcell differentiation stage. More specifically, in the proximal colon, both Tff3 and Muc4 are expressed only by the terminally differentiated goblet cells in the upper part of the crypt. In the distal colon, the expression of both these markers is concentrated in the upper part of the crypts but goblet cells throughout the crypts also stain positive for these markers. Changes in the proliferation-differentiation balance might therefore affect the expression of these markers differently in both regions. This mechanism needs to be further investigated, but already transcription factors, which control intestinal differentiation, may be of interest, that is, Cdx-1 and Cdx-2 were recently identified as important regulators of Muc4 expression in mice colon. 25 In addition, loss of differentiation of intestinal cells during damage, in general, has been shown in several animal models, by downregulation of distinct enterocyte-specific proteins. 14, 35, 36 The ABpositive cells at the crypt bases in the distal colon in the Muc2/IL-10 DKO mice could indicate transient expression of other mucins known to be expressed in the intestine or de novo expression of Muc6 mRNA as described for the Muc2 À/À mice.
14 Recent studies have implicated a role for membranebound mucins in signaling, contributing to the modulation of intestinal-cell proliferation and differentiation as reviewed by 37 Hollingsworth and Swanson. Both proliferation and differentiation are affected in the Muc2 À/À and Muc2/ IL-10 DKO mice, as determined by the increased proliferation of the distal colon as well as loss of differentiation in the goblet-cell lineage. Therefore, we investigated the expression of the two well-characterized membrane mucins, Muc1 and Muc3, in these mice. Muc1 mRNA was unaffected in all types of knockout mice, compared to WT mice. In contrast, Muc3 mRNA, although modestly downregulated in Muc2 À/À mice, was significantly downregulated in Muc2/IL-10 DKO mice. Muc3, specifically, has shown to stimulate cell migration, inhibit apoptosis and accelerated wound healing. 38 Significant downregulation of this mucin in the Muc2/IL-10 DKO could therefore partly explain and/or contribute to the severity in histological damage observed in these mice, compared to the singleknockout mice.
An increase in exposure to luminal antigens due to a diminished mucus layer (decrease of Muc2) could initiate inflammation. The Muc2/IL-10 DKO mice showed increased lymphocyte infiltration, that is CD3-positive cells, throughout the colon, which was more severe compared to Muc2 À/À mice. The increased infiltration coincided with upregulation of mRNA for the inflammatory cytokines TNF-a, IL-1b and IL-6 in the distal colon of Muc2/IL-10 DKO at 5 weeks of age. In addition, TNF-a, IFN-g and IL-6 were also significantly upregulated systemically in the Muc2/IL-10 DKO at 5 weeks of age. These pro-inflammatory cytokines play a pivotal role in the pathogenesis of IBD. 1, 3, 4 Furthermore, previous studies have shown that TNF-a/IL-1b/IL-6 are upregulated in both the IL-10 À/À and the Muc2 À/À mice, suggesting that similar types of immune responses are responsible for the inflammation observed. 14, 39 Previous studies also demonstrated that IL-10 is essential for producing transforming growth factor beta (TGF-b) and that, in agreement, IL-10 À/À mice lack TGF-b signaling. 40, 41 Lack of both IL-10 and TGF-b signaling in the Muc2/IL-10 DKO mice could explain the excessive inflammation in these mice compared to Muc2 À/À mice. In addition, the enhanced histological damage could be attributed to upregulation of IL-6, which has been shown to degrade the epithelial barrier and increase cell proliferation. 42 To summarize, the Muc2/IL-10 DKO mouse clearly demonstrates that combined abnormalities in immunoregulatory and epithelial factors greatly accelerate and exacerbate the phenotype of colonic inflammation. In fact, in our facility, the IL-10 À/À mice show no distinct clinical or histological signs of colitis at 5 weeks of age indicating that the mucus barrier offers enough protection under unchallenged conditions. Muc2
À/À mice, however, show abnormal morphology marked by thickening of the gut mucosa, flattening and ulceration of epithelial cells, general loss of architecture, increase of inflammatory cells, increase in proliferation and decrease of cell differentiation in the colon as described previously.
14 Therefore, this study provides evidence that in case of Muc2 deficiency, the anti-inflammatory cytokine IL-10 can control epithelial damage, though to a limited extent. Most importantly, these data show that the intestinal mucus layer in the intestine, more specifically its constituent mucin Muc2, is indispensable in mucosal protection, suggesting that impaired mucus barrier function is a major factor for the development of colitis.
